Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Institut d'Investigació Biomèdica Sant Pau in Spain seeks two R2A Junior Postdoctoral Researchers to advance methylation analyses and multi-omics work in cardiovascular disease contexts. The positions are tied to the UNSOLVED-CARDS Horizon Europe project and will be co-supervised by senior group leaders.
You will lead methylome‑wide analyses, interact with a multidisciplinary team, and contribute to high-impact publications.
Organisation/Company Institut d'Investigació Biomèdica Sant Pau Research Field Other Researcher Profile Recognised Researcher (R2) Positions Postdoc Positions Application Deadline 30 Nov 2026 - 15:00 (Europe/Madrid) Country Spain Type of Contract Permanent Job Status Full-time Hours Per Week 37,5 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
Call for applications for two R2A Junior Postdoctoral Researcher positions within the Complex Disease Genomics Research Group and the Pharmacogenomics and Stroke Genetics Research Group. Application deadline: 30 November 2026 at 3:00 p.m.
About the Project:
Methylation analyses and omics integration
We are seeking highly motivated and talented Postdoctoral Researchers wishing to further develop their scientific career in the area of Omics of Cardiovascular Disease to join our team in Institut de Recerca Sant Pau, Barcelona.
The postdoctoral researchers will work within the framework of the ambitious Horizon Europe project UNSOLVED-CARDS (Horizon-HLTH-2026-01-DISEASE-11), coordinated by our Institution, which explores shared and sex-specific mechanisms underlying cardiovascular diseases (CAD, stroke, and AAA) to develop targeted therapies and personalized risk prediction tools. We expect the selected Researchers to have a leading role in the project and its future publications.
We are looking for candidates to lead the methylome-wide analyses, examining the effects of methylation on large populations of cardiovascular disease patients. The successful applicant should be self-motivated, with the ability to work independently as well as in collaborative projects, have excellent written and oral communication skills, and be able to interact effectively and work productively in a team. We are particularly interested in candidates with a bioinformatics/statistics background who are well acquainted with data analysis and programming and are passionate about research in general and cardiovascular research in particular. Expertise in methylome analyses will be appreciated.
The position will be jointly hosted by the Genetics of Complex Disease and the Stroke Pharmacogenomics and Genetics groups and will be co-supervised by Dr Maria Sabater Lleal and Dr Israel Fernández Cadenas.
About the Research Groups
The Unit of Genomics of Complex Disease focuses its research activities on the acquisition, management, and analysis of multi-omics data, and their integration with clinical and biological data, with the aim of identifying novel biomarkers and developing risk prediction models to support clinical decision-making in patients with vascular diseases, including venous and arterial thrombosis and aneurysms.
The Neurovascular Pharmacogenomics and Genetics Group is a research team of 17 members dedicated to identifying new treatments and therapeutic targets through the use of multi-omics approaches, such as genome‑wide association studies (GWAS), epigenome‑wide association studies (EWAS), and proteomics. Their goal is to improve risk assessment and clinical outcomes in stroke and other neurological disorders.
The following will be valued
Duties
We Offer
The deadline for submitting applications is 30 November 2026 at 3:00 p.m.